The role of CAR T-cell immunotherapy in the treatment of blood cancers was discussed at the American Society of Hematology meeting.
The unleashed immune system can attack the healthy vital organs like the bowel, the liver, lungs, kidneys, adrenal and pituitary glands and others.
In the midst of fighting cancer, using one's immune system is said to be a promising way to beat the deadly disease.
A team of researchers at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has found that a significant number of lung cancer patients also have autoimmune disease, which may make them unsuitable for increasingly popular immunotherapy treatments.
A new kind of therapy aimed at addressing an immune system’s powerful T-cells could be out as early as next year if two pharmaceutical companies regulatory approval gains ground.
